Utilizing strategies that conserve active pharmaceutical ingredient (API) quantities and pinpointing scalable formulation technologies suitable for boosting drug solubility and augmenting oral…
INTRODUCTION The development of orally administered small molecules is becoming more challenging as an increasing number of molecules in pipelines have poor…
Download Full Case Study Abstract: This comprehensive case study offers an exhaustive examination into the precise development of an enteric-protected solid oral…
Overview Drug developers have to take into account several factors to position a pre-clinical drug candidate successfully for first-in-human clinical trials. This executive summary will outline…
Orphan drugs encounter challenges that extend from their initial discovery to eventual launch, primarily due to the restricted patient numbers and niche…